3-iodobenzylguanidine has been researched along with Heart Valve Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashino, K; Ebina, T; Inoue, T; Ishigami, T; Ishikawa, Y; Kuji, N; Matsubara, S; Minamisawa, K; Mitani, I; Ochiai, H; Oka, T; Sumita, S; Takahashi, N; Umemura, S | 1 |
| Imamura, M; Kubo, N; Mabuchi, M; Morita, K; Noriyasu, K; Tamaki, N; Tsukamoto, T; Yasuda, K | 1 |
| Azuma, A; Ito, K; Kohno, Y; Miyao, K; Nakagawa, M; Ohtsuki, K; Shiga, K; Sugihara, H; Taniguchi, Y; Terada, K | 1 |
| Burt, RW; Hackett, FK; Klein, LS; Miles, WM; Mitrani, RD; Wellman, HN; Zipes, DP | 1 |
| Fukuyama, T; Imamura, Y | 1 |
| Kurihara, T; Narita, M | 1 |
3 trial(s) available for 3-iodobenzylguanidine and Heart Valve Diseases
| Article | Year |
|---|---|
Clinical implications of cardiac (123)I-meta-iodobenzylguanidine scintigraphy and cardiac natriuretic peptides in patients with heart disease.
Topics: 3-Iodobenzylguanidine; Angina Pectoris; Atrial Natriuretic Factor; Cardiomyopathies; Chronic Disease; Female; Follow-Up Studies; Heart Diseases; Heart Valve Diseases; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2002 |
Sympathetic denervation and reinnervation after the maze procedure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiac Surgical Procedures; Denervation; Female; Heart; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Nerve Regeneration; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
[Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].
Topics: 3-Iodobenzylguanidine; Aged; Aortic Valve Insufficiency; Echocardiography; Female; Heart; Heart Failure; Heart Valve Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Insufficiency; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 1995 |
3 other study(ies) available for 3-iodobenzylguanidine and Heart Valve Diseases
| Article | Year |
|---|---|
Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Autonomic Nervous System Diseases; Cardiac Catheterization; Cardiomyopathies; Case-Control Studies; Catheter Ablation; Child; Echocardiography; Electrophysiology; Exercise Test; Female; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Sympathetic Nervous System; Tachycardia, Ventricular; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1993 |
[Myocardial adrenergic nerve activity in valvular diseases assessed by iodine-123-metaiodobenzylguanidine myocardial scintigraphy].
Topics: 3-Iodobenzylguanidine; Aged; Contrast Media; Echocardiography; Female; Heart; Heart Failure; Heart Valve Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Stenosis; Radionuclide Imaging; Sympathetic Nervous System | 1997 |
[Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathy, Dilated; Echocardiography; Female; Heart; Heart Failure; Heart Valve Diseases; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Ischemia; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Thallium Radioisotopes | 1998 |